Picture of Nyxoah SA logo

NYXH — Nyxoah SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Nyxoah Announces Acccess U.S. Pivotal Study Meets Primary Safety And Efficacy Endpoints In Complete Concentric Collapse Patients

BRIEF-Nyxoah Announces Acccess U.S. Pivotal Study Meets Primary Safety And Efficacy Endpoints In Complete Concentric Collapse Patients

- Nyxoah SA NYXH.BR:

  • NYXOAH ANNOUNCES ACCCESS U.S. PIVOTAL STUDY MEETS PRIMARY SAFETY AND EFFICACY ENDPOINTS IN COMPLETE CONCENTRIC COLLAPSE PATIENTS

  • NYXOAH - REPORTS 12-MONTH ODI RESPONDER RATE OF 87.7% (P<0.001) ON FULL ANALYSIS SET

  • NYXOAH - REPORTS 12-MONTH AHI RESPONDER RATE OF 77.2% (P<0.001) ON FULL ANALYSIS SET

Source text: ID:nGNX5Qmj4X

Further company coverage: NYXH.BR


((Reuters.Briefs@thomsonreuters.com;))

Recent news on Nyxoah SA

See all news